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Abstract
Rationale: Primary ciliary dyskinesia (PCD) is a genetically
heterogeneous recessive disorder of motile cilia, but the genetic cause
is not defined for all patients with PCD.
Objectives: To identify disease-causingmutations in novel genes, we
performed exome sequencing, follow-up characterization, mutation
scanning, and genotype-phenotype studies in patients with PCD.
Methods:Whole-exome sequencing was performed using
NimbleGen capture and Illumina HiSeq sequencing. Sanger-based
sequencing was used for mutation scanning, validation, and
segregation analysis.
Measurements and Main Results:We performed exome
sequencing on an affected sib-pair with normal ultrastructure in
more than 85% of cilia. A homozygous splice-site mutation was
detected in RSPH1 in both siblings; parents were carriers. Screening
RSPH1 in 413 unrelated probands, including 325 with PCD and 88
with idiopathic bronchiectasis, revealed biallelic loss-of-function
mutations in nine additional probands. Five affected siblings of
probands in RSPH1 families harbored the familial mutations. The 16
individuals with RSPH1mutations had some features of PCD;
however, nasal nitric oxide levels were higher than in patients with
PCD with other gene mutations (98.3 vs. 20.7 nl/min; P, 0.0003).
Additionally, individuals with RSPH1mutations had a lower
prevalence (8 of 16) of neonatal respiratory distress, and later onset of
daily wet cough than typical for PCD, and better lung function
(FEV1), compared with 75 age- and sex-matched PCD cases (73.0 vs.
61.8, FEV1 % predicted; P = 0.043). Cilia from individuals with
RSPH1mutations had normal beat frequency (6.16Hz at 258C), but
an abnormal, circular beat pattern.
Conclusions: The milder clinical disease and higher nasal nitric
oxide in individuals with biallelic mutations in RSPH1 provides
evidence of a unique genotype-phenotype relationship in PCD, and
suggests that mutations in RSPH1may be associated with residual
ciliary function.
Keywords: cilia; Kartagener syndrome; ciliopathy; exome
sequencing; RSPH1
At a Glance Commentary
Scientific Knowledge on the Subject: Primary ciliary
dyskinesia (PCD) is a rare genetically heterogeneous
disorder that is associated with low levels of nasal nitric
oxide and chronic otosinopulmonary disease. Pathogenic
mutations in 28 genes can cause PCD, which accounts for
approximately 70% of individuals affected with PCD.
What This Study Adds to the Field: This article describes
mutation profiling of RSPH1 in a large cohort of clinically
well-characterized patients with PCD. Patients with PCD with
mutations in RSPH1 have milder respiratory disease and
higher levels of nasal nitric oxide than seen in other “classic”
forms of PCD.
Primary ciliary dyskinesia (PCD) (MIM
244400) is a genetically heterogeneous
recessive disorder of motile cilia. Clinical
manifestations (neonatal respiratory distress,
early onset daily wet cough and nasal
congestion, chronic otosinopulmonary
disease, and male infertility) reflect abnormal
cilia and flagellar function (1, 2). Dysfunction
of specialized motile cilia at the ventral
node during embryogenesis caused by
mutations in many of the genes that cause
PCD may lead to random organ placement,
and approximately 50% of PCD affected
individuals have organ laterality defects (1–3).
Mutations in 28 genes are known to
cause PCD, and account for the genetic
etiology in approximately 70% of affected
individuals (1, 4–35). Most of these 28
genes result in defects in the ciliary
axoneme, which can be defined by electron
microscopic ultrastructural analysis (1).
In the absence of clear structural defects,
diagnosis of PCD remains challenging.
Nasal nitric oxide (nNO) production,
which is very low in patients with PCD
with ciliary ultrastructural defects or
mutations in DNAH11 (mean z21 nl/min),
compared with normal subjects (z305
nl/min) (36), is being used as an aid to
diagnosis. To date, there have been no
reports of mutations in genes that cause
PCD that are associated with a different
(milder or more severe) PCD phenotype,
compared with other PCD-causing gene
mutations. To further explore genotype-
phenotype relationships in PCD, we
performed exome sequencing in two
pediatric-aged siblings with a PCD-like
clinical phenotype, but apparently normal
ciliary ultrastructure and nNO values
(z98 nl/min) that were not in the typical
low range (z21 nl/min) for PCD. We
identified biallelic mutations in RSPH1 in
the two affected siblings and performed
follow-up testing for RSPH1 mutations in
a large number of other subjects with
PCD or bronchiectasis of unknown cause.
These studies defined a unique genotype-
phenotype relationship for patients with
PCD with mutations in RSPH1.
Methods
Protocol
We performed whole exome sequencing
in two siblings with PCD-like phenotype,
but normal ciliary ultrastructure and
nondiagnostic nNOvalues. After identification
of biallelic mutations in RSPH1 in the
probands, we tested for additional mutations
in RSPH1 in 413 unrelated individuals,
including 117 PCD-affected probands with
normal or nondiagnostic ciliary ultrastructure
and nNO levels of less than 100 nl/min,
175 PCD-affected probands with outer
dynein arm (ODA) 6 inner dynein arm
(IDA) defects or IDA 6 microtubular
disorganization, 33 PCD-affected probands
without available ciliary ultrastructure, and
88 probands with idiopathic bronchiectasis
and nNO greater than 100 nl/min.
Genetic Testing
As previously described, exome sequencing
was performed (NimbleGen v2 in-solution
hybrid capture and Illumina HiSeq 2,000
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sequencing) (37), sequences were aligned to
the human reference genome (hg19) (38),
single-nucleotide and insertion-deletion
variants were called with GATK (39)
(see Table E1 in the online supplement),
SeattleSeq server was used for variant
annotation, and common variants were
filtered out (see Table E2) (11, 29, 37). Six
genes had biallelic variants consistent with
a recessive model and present in both
affected siblings (see Tables E1 and E2).
RSPH1 was prioritized for validation (primer
sequences in Table E3) by Sanger sequencing
(Life Technologies, Carlsbad, CA) based
on pathogenic potential, relevance of the
gene to PCD, and analysis of large-scale
coexpression datasets (11, 29, 40). On variant
validation, segregation analysis was defined
in parents and available family members
of probands. Several methods were used to
test for RSPH1 mutations in 413 unrelated
individuals (see Table E4), including Sanger-
based high-throughput sequencing (RS&G
Seattle; RC2-HL-10292) or at University
of North Carolina (capillary electrophoresis),
primer sequences in Table E3 (n = 71),
additional whole-exome sequencing and
targeted screening for RSPH1 (n = 6), or
a recently developed high throughput
exon-sequencing technique (n = 336) (41).
Analysis of Cilia Function
Freshly obtained nasal epithelia had analysis
of ciliary movement and beat frequency, as
reported (42). For in vitro studies, airway
epithelia were expanded from nasal scrape
biopsies using fibroblast conditioned media
and Rho kinase inhibitor, Y-27632 (43).
Cells were plated on porous filters and
cultured at air-liquid interface until ciliary
differentiation. High-speed videos (250 fps)
were recorded (Nikon Eclipse TE-2000
inverted microscope [Nikon Instruments
Inc., Melville, NY] and Roper ES-310T
camera [Redlake MASD, Inc., San Diego,
CA]), and ciliary beat frequency assessed
(42). Waveform motion was analyzed by
replaying the videos in slow motion and
recording the positions of individual cilia.
Statistical Analysis
Linear regression (age and sex as covariates)
was used to compare lung function
(FEV1, % predicted) between 15 RSPH1-
affected subjects and 75 age- and sex-
matched non-RSPH1 patients with PCD. A
t test (unequal variance 1-trial) was used to
compare nNO between 16 RSPH1 patients
and 149 patients with PCD with ciliary
ultrastructural defects or mutations in
DNAH11 (36). Pair-wise t tests were used
to compare ciliary motion (planar vs.
rotational deviation from planar) between
cultured ciliated cells from a clinically
normal RSPH1 carrier and two RSPH1-
affected patients with PCD.
Institutional Review Board Approval
The study was approved by the institutional
review board for the Protection of the Rights
of Human Subjects at the University of North
Carolina and collaborating institutions.
Written informed consent was obtained from
study participants and/or their parents.
Results
We identified a homozygous splice variant
(c.275–2A.C) in RSPH1 (RefSeq:
NM_080860.2) in an affected sib-pair
(#1444 [II-1]; #1774 [II-2]) who had
normal ciliary ultrastructure in
approximately 85% of their nasal cilia and
nNO values approximately 90 nl/min
(Table 1). Sanger sequencing confirmed
inheritance in trans for these two siblings
(Table 1; see Figure E1). Taken together,
these data suggest mutations in RSPH1 are
likely the cause of PCD in this family.
We tested for mutations in RSPH1 in
413 additional unrelated individuals and
identified biallelic mutations in an
additional 14 individuals (nine unrelated
families) with PCD, but none in individuals
with idiopathic bronchiectasis. Thus,
biallelic mutations in RSPH1 were found in
a total of 10 families (16 individuals
affected with PCD), and segregation
analysis confirmed that the mutations were
inherited in trans in the five families that
could be tested, consistent with recessive
inheritance (Table 1; see Figure E1). We
also noted monoallelic mutations in three
unrelated individuals. Despite RSPH1
mutations in 13 unrelated kindreds, there
were just four different putative mutations
(Table 1, Figures 1 and E1), of which
c.275–2A.C (disrupting a splice acceptor)
represented 14 alleles (nine unrelated
families); c.85G.T (p.Glu29*) represented
six alleles (four unrelated families);
c.407_410delAGTA (p.Lys136Metfs*6)
represented two alleles (two unrelated
families); and a single allele, c.287dupA
(p.Asn96Lysfs*2) represented one individual.
Two of the four putative mutant alleles
(c.275–2A.C and c.85G.T) are in the
single-nucleotide polymorphism database
and exome variant server as rs151107532
and rs138320978, respectively. The minor
allele frequencies in European Americans
were low for both these variants (0.0011
minor allele frequencies [9 of 8,600] for
c.275–2A.C and 0.0006 minor allele
frequencies [5 of 8,600] for c.85G.T).
Of the three putative mutant alleles that
were observed in at least two unrelated
families, haplotype analysis suggested these
are founder mutations in individuals with
Northern European ancestry (see Figure
E2). In subjects from four families with
homozygous mutations, parental DNA was
unavailable. However, based on haplotype
analysis, we conclude that these individuals
likely carry homozygous mutations.
We noted monoallelic mutations in
RSPH1 in three additional families (n = 5
subjects) (see Table E5). One affected
individual (#1473 [II-1]) also carried two
disease-causing mutations in DNAH5
(NM#001369.2) and had a ciliary ODA
defect. In another family (#548), affected
siblings were not concordant for the RSPH1
mutation (see Table E5, Figure E1). Thus, it
is very unlikely that RSPH1 mutations are
PCD-causing in these two families. In the
third family (#552) with only one mutant
allele, it is possible that there is another
mutation that is undetected in RSPH1 in
the region that was not interrogated;
alternatively, these individuals may have
PCD-causing mutations in another gene.
Thirteen benign variants were identified in
this study (see Table E6).
To examine the functional significance
of the c.275–2A.C splice site mutation,
RNA was prepared from nasal epithelia
obtained from two siblings (#1187
[II-1]; #1196 [II-2]) homozygous for the
mutation. RNA was also isolated from an
individual (#1371 [III-2]) compound
heterozygous for c.275–2A.C and
c.287dupA mutations and an unaffected
mother (#1373 [II-2]) carrying c.275–2A.
C mutation. Qualitative reverse-transcriptase
polymerase chain reaction (RT-PCR)
analysis using primers specific for exons 2
and 9 revealed a single major product of the
expected size (930 bp) in RNA prepared
from normal airway epithelia (Figure 2A). In
contrast, RNA from the subject homozygous
for the c.275–2A.C mutation produced
primarily two shorter transcripts and
several minor transcripts. One shorter
(631 bp) transcript was caused by an
out-of-frame deletion of exons 4–6
(r.275–573del [p.Glu93Lysfs*24]) and
ORIGINAL ARTICLE
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another shorter (731 bp) transcript was
caused by an out-of-frame deletion of exons
4–5 (r.275_501del [p.Gly92Alafs*10]), both
leading to premature termination signals
(Figure 1). The three minor products also
represent aberrant transcripts (see Figure
E3). Qualitative RT-PCR analysis of RNA
from subject (#1187 [II-1]) homozygous for
c.275–2A.C, using another primer set
specific for exons 2–5, showed multiple
aberrant transcripts (see Figure E3). RNA
from the subject (#1371 [III-2]), compound
heterozygous for mutations c.275–2A.C
and c.287dupA, and an unaffected mother
(#1373 [II-2]) who carried the c.275–2A.C
mutation, was subjected to qualitative RT-
PCR with exons 2–5 primers. A mixture of
transcripts with apparently full-length
products (either 417 bp for the wild-type
transcript in the mother or 418 bp for the
c.287dupA transcript in the affected
subject) and a larger size (567 bp) transcript
were obtained. The larger transcript was
caused by the 150-bp insertion of intron 3
from the 39end, causing a frameshift and
resulting in premature termination
(r.275–2A.C; r.275–1_275–150ins
[p.Glu93Phefs*25]; data not shown). Western
blotting of a total cell lysate prepared from
nasal epithelia from a normal subject or
from cultured human bronchial epithelial
(HBE) cells revealed a strong RSPH1 signal,
whereas no signal was detected in nasal
epithelia from a subject affected with PCD
(#1370 [III-1]) harboring compound
heterozygous mutations (c.275–2A.C and
c.287dupA) (Figure 2B).
To investigate the expression of RSPH1
in ciliated cells, HBE cells were cultured at
air-liquid interface and RNA was isolated
at different times during differentiation
(44). Figure 3A shows that RSPH1 was not
expressed early in culture (Days 4 and 8),
but was strongly expressed thereafter. This
pattern parallels the expression of dynein
Figure 1. Genomic organization, location of primary ciliary dyskinesia (PCD)-causing mutations, and transcript analysis of RSPH1. (A) Schematic showing
genomic organization of RSPH1 (NM_080860.2), consisting of nine exons with 1,430 bp transcript, encoding 309 amino acids protein. Solid box
designates exons “E,” horizontal lines designates introns “IVS,” and locations of 59UTR, 39UTR, start and stop codons are shown. Introns/exons are not
drawn to scale. The positions of all four identified RSPH1 putative mutations are indicated. (B and C) Homozygous (2/2) mutation in affected (bottom),
heterozygous (1/2) carrier (middle), and corresponding wild-type (WT) sequences in control (top) for c.85G.T (p.Glu29*) and c.275–2A.C (splice
acceptor site) mutations, respectively. (D and E) Heterozygous (1/2) mutation in affected (bottom) and corresponding WT sequences in control (top) for
c.287dupA (p.Asn96Lysfs*2) and c.407_410delAGTA (p.Lys136Metfs*6) mutations, respectively. (F) Schematic showing WT transcripts of RSPH1. (G–J)
Effect of homozygous c.275–2A.C splice acceptor site mutation from affected individual (#1187 [II-1]) was interrogated using reverse-transcriptase
polymerase chain reaction with 2F19R primers (see Table E3 for primer sequences). Two major transcripts and multiple minor transcripts were observed.
(G and H) Major transcript 1 and 2 led to the out-of-frame deletion of exons 4–6 and exons 4 and 5, respectively, resulting in the premature translation
termination signal. Schematic of the mutant transcripts and the corresponding electropherograms with exact location of the out-of-frame deletions
are shown. Additional minor mutant transcripts are depicted in Figure E3. Forward and reverse primers are designated as “F” and “R,” respectively, along
with their cDNA locations, and amplicon sizes are shown in red fonts. Base sequence, amino acid sequence, and codon numbers are shown. Locations
of the mutations are designate by an arrow and exon-exon junctions are shown by the vertical solid red lines. Further details with 2F15R primer set
are depicted in Figure E4.
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axonemal intermediate chain 1 (DNAI1
[NM_012144.2]), another gene in which
mutations cause PCD (24, 30), which
suggests RSPH1 plays a specific role in
ciliated cells. In our studies, RSPH1 was
not detected by Western blot in lysates of
undifferentiated HBE cells, whereas a clear
signal was present in lysates of differentiated
(ciliated) cultures, in agreement with the
RNA data (Figure 3B). A strong signal for
RSPH1 was also observed in detergent
isolated axonemes, demonstrating that the
RSPH1 protein is an integral part of the
ciliary axoneme. Immunocytochemistry of
HBE cells showed that the RSPH1 antibody
reacted with the cilia (Figure 3C), whereas
no signal was observed with control IgG,
further confirming the ciliary location of
RSPH1. Taken together, these studies
demonstrate that RSPH1 is expressed during
ciliated cell differentiation, is an integral
protein of the axoneme, and mutations in
RSPH1 can be PCD-causing.
The clinical manifestations of
otosinopulmonary disease in our subjects
with biallelic mutations in RSPH1
resembled those in individuals with classic
PCD with dynein arm defects, because all
subjects developed bronchiectasis by their
mid-late teenage years (Table 1), and most
had recurrent otitis media and sinusitis
starting in childhood. However, the
prevalence of neonatal respiratory distress
was lower (50%) than seen in classic PCD
(75–85%), and only two subjects were
reported to have an onset of daily year-
round wet cough within the first year of life
that characterizes 75–85% of cases with
classic PCD (1). To assess severity of the
lung disease in individuals with biallelic
RSPH1 mutations, we compared their lung
function (FEV1% predicted) with
individuals defined by ultrastructural
defects and/or biallelic PCD-causing
mutations in other (non-RSPH1) genes
(45). One of our 16 cases with biallelic
mutations in RSPH1 could not be used for
this comparison of lung function, because
a cystadenomatoid lung malformation
required pulmonary resection within the
first 24 hours after birth. The other 15 cases
with biallelic mutations in RSPH1 were
Figure 2. Effect of the c.275–2A.C splice site mutation on RSPH1 expression in vivo. (A) RNA was
prepared from cultured human bronchial epithelial (HBE) cells from a normal subject and nasal scrape
biopsies from individuals with primary ciliary dyskinesia (PCD) (#1196 [II-2], #1187 [II-1]) with homozygous
splice site (c.275–2A.C) mutations, a carrier (#1373 [II-2]) with one splice site (c.275–2A.C) mutation, and
an individual (#1371 [III-2]) with a splice site (c.275–2A.C) and a frameshift (c.287dupA) compound
heterozygous mutations. Reverse-transcriptase polymerase chain reaction of the control sample resulted
in a single, full-length product of approximately 930 bp, whereas the c.275–2A.C mutation resulted in
predominantly two smaller products of approximately 650 and 750 bp, along with multiple other
aberrantly spliced products (brightest fragment on ladder represents 500 bp). Heterozygous individuals
generated a mixture of the full-length and aberrant products. Extra lanes between the samples and the
marker lane were removed from the image, as indicated by the white line. (B) Western blot of total
protein from a normal control nasal biopsy, a PCD subject (#1370 [III-1]) with a splice site (c.275–2A.C)
and a frameshift (c.287dupA) compound heterozygous mutations, and cultured (normal) HBE cells.
The PCD sample shows no clear signal for RSPH1. The blot was reprobed with an antibody against
DNALI1 to demonstrate the presence of approximately equal numbers of cilia between samples.
Figure 3. Expression of RSPH1 in cultured human bronchial epithelial (HBE) cells. (A) Control HBE cells were cultured at an air-liquid interface for the
indicated time and total RNA was isolated (44). Reverse-transcriptase polymerase chain reaction with specific primers demonstrates that RSPH1 and
DNAI1 (NM_012144.2) are not expressed in early, undifferentiated cultures, but are induced during ciliated cell differentiation. Cyclophilin A (PPIA)
(NM_021130.3) expression (positive control) does not change over time. (B) Western blot of total cell lysates from undifferentiated and differentiated HBE
cells and isolated ciliary axonemes (50). RSPH1 is not detected in the undifferentiated cells, but is present in the differentiated cell lysates and in the
isolated ciliary axonemes. Extra lanes between the samples were removed from the image, as indicated by the black line. Two separate Western blots
were probed with RSPH1 (top) and DNAI1 (bottom). (C) Cultured HBE cells were immunostained with a monoclonal antibody against RSPH1 or with
control IgG. The RSPH1 antibody clearly reacts with the cilia, confirming the presence of RSPH1 in the axoneme.
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compared with 75 age- and sex-matched
individuals with classic PCD, using linear
regression (age and sex as covariates). The
FEV1 (% predicted) was better in RSPH1
cases by approximately 11% (73.0 vs. 61.8,
% predicted; P = 0.043) (see Table E7), which
is congruent with less prominent respiratory
symptoms early in life in RSPH1 patients.
We also noted that FEV1 was better (~11%)
in 15 RSPH1 cases when we restricted age
and gender matching (1:3) to 45 subjects
with dynein arm defects (ODA and ODA 1
IDA) (see subscript to Table E7).
Another striking difference in the
phenotype of subjects with mutations in
RSPH1 was a higher level of nNO production
than has been previously reported for
mutations in any of the other PCD-causing
genes, including DNAH11, which is
associated with normal ciliary ultrastructure
(1, 10). The mean nNO in 149 prospectively
studied PCD cases with ciliary ultrastructural
defects or mutations in DNAH11 was 20.7
nl/min (36), whereas the mean nNO value
in our 16 subjects with RSPH1 mutations
was nearly fivefold higher (98.3 nl/min; P ,
0.0003). Indeed, 10 of these 16 RSPH1
individuals had nNO values that were above
the disease-specific cutoff value (77 nl/min)
that we recently established in 149 individuals
affected with PCD versus 78 healthy subjects
and 146 disease-controls (36).
Quantitative ultrastructural analysis of
756 cilia from 15 subjects with biallelic
mutations in RSPH1 showed that 80.16 8.4%
(mean6 SD) of the cilia had a normal 91 2
and dynein arm ultrastructure, although
radial spokes were not well seen (Figure 4).
The percentage of cilia from RSPH1 patients
with normal ultrastructure is lower than seen
in normal subjects in our hands (92.6 6
6.1%, data not shown) and the study by
Papon and coworkers (95%) (46). In the cilia
from RSPH1 subjects with clear-cut defects,
the most common abnormalities were
absence of the central pair (z12%) and
translocation of an outer doublet into the
central region (z5%) with or without
a central pair being present (Figure 4).
However, the percentage of cilia with normal
ultrastructure in individuals with biallelic
mutations in RSPH1 ranges from 63.4%
to 93.1%, which overlaps with the range
(80–100%) from the control individuals (46);
indeed, less than half (7 of 16) of the subjects
with RSPH1 mutations had more central
apparatus defects than the lower range
reported in cilia from normal subjects (46).
We assessed ciliary waveform by high-
speed video microscopy in freshly obtained
nasal epithelia from nine subjects with
biallelic mutations in RSPH1, and measured
ciliary beat frequency (Sisson-Ammons
Video Analysis; room temperature) in
samples from four of these subjects (42).
The mean ciliary beat frequency (6.1 6
1.7 Hz) was only slightly lower than
normal (7.3 6 1.5 Hz) from multiple
measurements in 10 random fields (42).
When cilia were viewed from a lateral
perspective (see Videos E1 and E2), the
RSPH1 cilia showed vigorous activity,
but a slightly reduced range of motion
compared with normal, and some
fields showed mild dyskinesia (poorly
coordinated movement) with adjacent cilia.
When viewed from above (see Videos E3 and
E4), the cilia exhibited rotational (clockwise)
movement (for control, see Video E5).
To examine the effect of mutations in
RSPH1 on ciliary function in the absence
of infection and inflammation, ciliary motion
of cultured epithelia was analyzed by
replaying high-speed videos in slow motion
and recording the positions of individual
cilia. For each sample, three to five cilia
from three separate cells were tracked over
Figure 4. Electron micrographic findings. A total of 756 ciliary cross-sections were scored from 15 subjects affected with primary ciliary dyskinesia (PCD)
with biallelic mutations in RSPH1, and representative images are shown. (A) Normal (9 1 2) axonemal structure including outer doublet and the central
apparatus (80.1% of cilia images). (B and C) Complete absence of the central apparatus (9 1 0), or electron-dense material in central area (12.1% of
cilia images). (D–F) Translocation of outer doublet to either replace central pair or into the central region (8 1 1) with extra singlet microtubule, or other
abnormalities including eight outer doublets without normal central apparatus (8 1 0) (5.1% of cilia images). (G) A single microtubule in the center instead
of central pair (9 1 1) (1.4% of cilia images). (H) Off-center central pair with extra singlet (1.2% of cilia images).
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several cycles. Cilia from the clinically
unaffected (heterozygous carrier) mother
(#1373 [II-2]) beat in a mostly planar (back
and forth) motion, whereas cilia from the
affected siblings (#1370 [III-1] and #1371
[III-2]) moved in a circular pattern
(Figure 5). When viewed from above, the
cilia exhibited rotational (clockwise)
movement, similar to the rotational
movement of nodal (9 1 0) cilia (47).
Quantitative analysis (Figure 5) demonstrated
that the rotational waveform of cilia from two
siblings with biallelic mutations in RSPH1
was different from the planar waveform of
cilia from the carrier mother (#1373 [II-2])
(P , 6.4 3 108). Thus, although mutations
in RSPH1 do not greatly reduce ciliary
activity, the ciliary waveform is altered
(Figure 5; see Videos E6–E8).
Discussion
PCD is a genetically heterogeneous,
autosomal-recessive disorder; indeed,
mutations in 28 genes have been
reported to cause PCD (1, 4–35).
However, there has been no previous
report of any unique genotype-phenotype
association in PCD. This study of
patients with biallelic mutations in
RSPH1 is the first to demonstrate
an association between loss-of-function
mutations in a PCD-causing
gene and a milder clinical phenotype and
higher levels of nNO, as compared
with patients with PCD with typical
ultrastructural defects or mutations in
genes that are commonly associated with
PCD.
Our discovery of mutations in RSPH1
as PCD-causing is congruent with the
recent report of RSPH1 mutations in PCD
by Kott and coworkers (35), although that
study did not discuss any genotype-
phenotype associations. The discovery of
RSPH1 as a PCD-causing gene is also
congruent with what is known about the
protein product of RSPH1. Radial spoke
head 1 homolog (RSPH1; 309 amino-acids;
NP_543136) is approximately 40% identical
to the Chlamydomonas radial spoke
protein 1 (RSP1; 814 amino-acids;
XP_001693353), a component of the
radial spoke head in flagellar axonemes
(Figure 1) (48). Although there are no
Chlamydomonas RSP1 mutant strains
available, strains that are missing the radial
spoke head because of mutations in RSP4,
RSP6, or RSP9 all show obvious motility
defects. Human RSPH1 contains six
membrane occupation and recognition
nexus domains, which regulate intracellular
Ca21 signaling (49).
Our studies showing expression of
RSPH1 during differentiation of ciliated
airway epithelia, and the presence of
RSPH1 in detergent isolated axonemes of
normal cilia, demonstrate that RSPH1 has
a role in ciliated cells, and is an integral
protein of the ciliary axonemes. These data
are consistent with recent immunoelectron
microscopic studies that have localized
RSPH1 to the radial spoke region of the
sperm flagellum, and immunofluorescence
studies that show localization of RSPH1 to
the cilia of epithelia in the trachea and
ependyma (35, 49).
Because RSPH1 mutant respiratory
cilia have intact dynein arms, ciliary
velocity is not very affected by the radial
spoke mutations. Our studies clearly
document that RSPH1 mutant cilia have
a clockwise rotational movement when
viewed from above, and the waveform
approximates the circular movement of
nodal cilia, which lacks the central
apparatus (47). Others have reported that
ciliary motility in PCD-affected individuals
harboring mutations in radial spoke head
genes (RSPH4A and RSPH9) resembles the
rotary movement of nodal (9 1 0) cilia (6).
It is noteworthy that all 16 individuals
with biallelic mutations in RSPH1, including
the nine with homozygous splice site
variants, had situs solitus (Table 1). This is
congruent with reports of other patients
with PCD who have radial spoke head
mutations in RSPH4A (NM_152732.4) and
Figure 5. Mutations in RSPH1 result in a circular wave form. (A) Nasal epithelial cells from
a heterozygous carrier mother (#1373 [II-2]), and (B and C) two affected children (#1370 [III-1] and
#1371 [III-2]) were expanded in culture (43) and allowed to differentiate at the air-liquid interface (44).
High-speed videos were recorded from above the cultures and analyzed in slow motion (see Videos
E6–E8). (A) The cilia on three individual cells from the carrier mother (#1373 [II-2]) beat in a mostly
planar (back and forth) direction. (B and C) The cilia on three individual cells from each of the children
affected with primary ciliary dyskinesia (PCD) (#1370 [III-1] and #1371 [III-2]) moved in a clockwise
circle when viewed from above. To compare the ciliary activity quantitatively, a line of best fit was
determined for each cilia track. The mean distance (dmean) of the cilium from that line and the
maximum distance (dmax) from the centroid along that line were calculated. The dmean values
(micrometers, 6 SD) were 0.27 6 0.26 (n = 15) for the mother (#1373 [II-2]) but much greater
for children affected with PCD (#1370 [III-1], 0.53 6 0.10 [n = 10]; #1371 [III-2], 0.36 6 0.13 [n = 13]).
The ratio of these values (r = dmean / dmax) gives a measure of the ciliary beat shape with
a lower value denoting a straighter, more planar, beat. The r values for the PCD cells
(#1370 [III-1], 0.35 6 0.068; #1371 [III-2], 0.36 6 0.085) were significantly different than
those of the carrier mother (#1373 [II-2], 0.11 6 0.08; P , 6.4 3 108), reflecting the
defective ciliary activity.
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RSPH9 (NM_001010892.2) (6, 32, 35). The
lack of laterality defects is consistent with
the recognition that the 9 1 0 embryologic
nodal cilium does not contain radial spokes
and is unaffected by central apparatus
defects; therefore, normal organ
lateralization is preserved during
embryogenesis.
The findings of our study have
important implications for PCD,
particularly as relates to genotype and
phenotype. First, three of the four mutations
we describe were included in the recent
report by Kott and coworkers (35). Our
haplotype analysis demonstrated that three
of these mutations are likely to be founder
mutations in individuals with Northern
European ancestry (see Figure E2). The data
in Kott and coworkers are consistent with
this interpretation, but they did not provide
any haplotype analysis (35). Second, our in-
depth analysis of the clinical and ciliary
phenotype of individuals with RSPH1
mutations indicates that they have milder
respiratory disease than PCD individuals
with mutations in other published genes,
including DNAH11, which is associated
with normal ciliary ultrastructure;
specifically, individuals with RSPH1
mutations had a lower incidence of
neonatal respiratory distress, a later onset
of daily year round wet cough, better lung
function, and significantly higher levels of
nNO. Our results are consistent with those
of Kott and coworkers (35), who reported
that only 4 of the 12 subjects they studied
had neonatal respiratory distress, whereas
two of their four subjects with data had
nNO levels greater than 77 nl/min, which
is the disease-specific cutoff in PCD (36).
Third, although the mechanism responsible
for the milder phenotype and higher nNO
values is unknown, waveform analysis
that we performed in nasal epithelial cells
cultured in the absence of infection and
inflammation demonstrated that RSPH1
mutant cilia beat with an almost normal
frequency, but with a circular waveform
similar to that reported for mutations in
two other radial spoke genes, RSPH4A and
RSPH9 (6, 32). However, patients with
mutations in RSPH4A and RSPH9 seem
to have a typical PCD phenotype (6, 32),
including low nNO values (average, 14.2
nl/min; range, 5.9–22.6 nl/min; n = 8)
(6, 32). We speculate that RSPH1 mutant
cilia may have some residual functional
activity to stimulate nitric oxide synthases
in the ciliated cell apical membrane, and
produce more nitric oxide than individuals
with classic PCD (1). Fourth, the higher
level of nNO in RSPH1 individuals is of
particular importance, because nNO is
being used to assist with screening and
diagnosing PCD in subjects without
clear-cut ciliary ultrastructure defects.
Because approximately 50% of the subjects
with PCD in our study had normal
ultrastructure in more than 80% of their
cilia, the higher levels of nNO and milder
disease phenotype makes it challenging to
confirm a correct diagnosis, unless genetic
testing is performed. Finally, it is likely that
mutations in other genes will be identified
that result in higher nNO and a milder
PCD phenotype; however, these cases are
not currently recognized and will likely
require discovery and confirmation
by genetic testing. Ultimately, the
identification of additional mutations
in novel genes that cause PCD, and
implementation of genetic testing, will
result in improved diagnosis, clinical care,
and outcomes in affected individuals. n
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